
Opinion|Videos|May 3, 2024
Addressing Unmet Needs and Disease Progression Challenges in Pulmonary Arterial Hypertension Management
Author(s)Ioana Preston, MD
Ioana Preston, MD, discusses unmet needs in the management of pulmonary arterial hypertension (PAH) and the challenges associated with the progressive nature of the disease.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What are the major unmet needs in the management of pulmonary arterial hypertension (PAH) that contribute to high mortality and morbidity rates?
- How does the progressive nature of PAH pose challenges in maintaining long-term symptom control and slowing disease progression?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM
2
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
3
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
4
Most Patients With MCL in Study of Pirtobrutinib Show Stable or Improved Physical Symptoms, QOL
5









